Maksim A. Sabantsev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Maksim A. Sabantsev has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Svetlana V. Shramko
Novokuznetsk State Institute for Further Training of Physicians – Branch Campus of the Russian Medical Academy of Continuous Professional Education
6 shared publications L. G. Bazhenova
3 shared publications- Anna Egorovna Vlasenko
Samara State Medical University of the Ministry of Health of the Russian Federation
1 shared publication E. P. Khvostova
1 shared publicationL. A. Markina
1 shared publication- Lyudmila F. Gulyaeva
Institute for the Medicine and Medical Technology, Novosibirsk State University, Pirogova Street, 1, Novosibirsk 630090, Russia
1 shared publication
Latest Publications
- 30 April 2026
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 4_2026, 121-127
Proliferative endometrial diseases: cytokine and macroglobulin spectrum
- 30 April 2026
- Published by Bionika Media in Akusherstvo i ginekologiia
- Vol. 4_2026, 121-127
Proliferative endometrial diseases: cytokine and macroglobulin spectrum
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (2) , 38-46
CLINICAL AND ANAMNESTIC PROFILES OF PATIENTS WITH PROLIFERATIVE ENDOMETRIAL DISEASES
Objective. To identify characteristic clinical and anamnestic features in patients with various proliferative endometrial diseases. Materials and Methods. A retrospective study was conducted involving 176 patients diagnosed with endometrial polyp (EP, n=58), endometrial hyperplasia without atypia (EH, n=52), endometrial hyperplasia with atypia (EHA, n=24), and endometrial cancer (EC, n=42). Data were analyzed based on medical history, clinical presentation, gynecological status, and somatic health. Statistical analysis was performed using the χ² test, Mann-Whitney test, and Kruskal-Wallis test. Results. The mean age of patients progressively increased across the groups: EP (45.3±0.9 years) → EH (46.6±1.2 years) → EHA (53.8±2.5 years) → EC (67.7±1.7 years). Heavy menstrual bleeding was noted in patients with EP (60.4%), while abnormal uterine bleeding was typical for EH (46.2%), and postmenopausal bleeding was predominant in EC (85.7%). In patients with EHA, a notable association was observed with multiple intrauterine interventions (75%), alongside high rates of infertility (12.5%) and recurrent miscarriage (8.4%). Women with EP more frequently presented with chronic pelvic inflammatory disease (24.1%) and anemia (39.7%); those with EH had a higher incidence of functional ovarian cysts (44.2%) and varicose veins of the lower extremities (21.1%); patients with EHA commonly exhibited obesity (37.5%) and gastrointestinal diseases (37.5%); and individuals with EC frequently had cardiovascular diseases (88.1%) and obesity (26.2%). Conclusion. Statistically significant differences were identified in the clinical and anamnestic characteristics of women with proliferative endometrial diseases. The key markers include the patient's age and the type of uterine bleeding.
- 1 January 2026
- Published by Altay State Medical University in Bulletin of Medical Science
- Vol. 38 (2) , 38-46
CLINICAL AND ANAMNESTIC PROFILES OF PATIENTS WITH PROLIFERATIVE ENDOMETRIAL DISEASES
Objective. To identify characteristic clinical and anamnestic features in patients with various proliferative endometrial diseases. Materials and Methods. A retrospective study was conducted involving 176 patients diagnosed with endometrial polyp (EP, n=58), endometrial hyperplasia without atypia (EH, n=52), endometrial hyperplasia with atypia (EHA, n=24), and endometrial cancer (EC, n=42). Data were analyzed based on medical history, clinical presentation, gynecological status, and somatic health. Statistical analysis was performed using the χ² test, Mann-Whitney test, and Kruskal-Wallis test. Results. The mean age of patients progressively increased across the groups: EP (45.3±0.9 years) → EH (46.6±1.2 years) → EHA (53.8±2.5 years) → EC (67.7±1.7 years). Heavy menstrual bleeding was noted in patients with EP (60.4%), while abnormal uterine bleeding was typical for EH (46.2%), and postmenopausal bleeding was predominant in EC (85.7%). In patients with EHA, a notable association was observed with multiple intrauterine interventions (75%), alongside high rates of infertility (12.5%) and recurrent miscarriage (8.4%). Women with EP more frequently presented with chronic pelvic inflammatory disease (24.1%) and anemia (39.7%); those with EH had a higher incidence of functional ovarian cysts (44.2%) and varicose veins of the lower extremities (21.1%); patients with EHA commonly exhibited obesity (37.5%) and gastrointestinal diseases (37.5%); and individuals with EC frequently had cardiovascular diseases (88.1%) and obesity (26.2%). Conclusion. Statistically significant differences were identified in the clinical and anamnestic characteristics of women with proliferative endometrial diseases. The key markers include the patient's age and the type of uterine bleeding.
- Open Access
- 27 April 2023
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 25 (1) , 49-54
Prediction of adenomyosis in patients with uterine fibroids
Aim. To determine the clinical, anamnestic, and immunological predictors of adenomyosis by developing a prognostic model of uterine fibroids with concomitant adenomyosis. Materials and methods. A retrospective single-center study was conducted at Kurbatov Novokuznetsk City Clinical Hospital №1, from 2012 to 2019. The model included 284 women with histologically confirmed uterine fibroids, of which 34.9% (99/284) were fibroids with adenomyosis and 65.1% (185/284) were isolated uterine fibroids. Logistic regression was used to develop the mathematical model. Results. Predictors of adenomyosis in patients with uterine fibroids have been established: age 43 years and older, concomitant endometrial hyperplasia, chronic inflammatory diseases of the cervix, menometrorrhagia, history of childbirth, history of endometrial disorders, varicose veins of the lower extremities, history of appendectomy, blood serum lactoferrin of more than 1.8 mg/L, interleukin-6 levels more than 2.8 pg/mL. The model has an accuracy of 91%, a sensitivity of 90%, a specificity of 92%, a positive predictive value of 85%, and a negative predictive value of 94%. Conclusion. The established predictors of adenomyosis allow for predicting the risk of adenomyosis in patients with uterine fibroids, facilitating effective treatment choices.
- 27 April 2023
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 25 (1) , 49-54
Open AccessPrediction of adenomyosis in patients with uterine fibroids
Aim. To determine the clinical, anamnestic, and immunological predictors of adenomyosis by developing a prognostic model of uterine fibroids with concomitant adenomyosis. Materials and methods. A retrospective single-center study was conducted at Kurbatov Novokuznetsk City Clinical Hospital №1, from 2012 to 2019. The model included 284 women with histologically confirmed uterine fibroids, of which 34.9% (99/284) were fibroids with adenomyosis and 65.1% (185/284) were isolated uterine fibroids. Logistic regression was used to develop the mathematical model. Results. Predictors of adenomyosis in patients with uterine fibroids have been established: age 43 years and older, concomitant endometrial hyperplasia, chronic inflammatory diseases of the cervix, menometrorrhagia, history of childbirth, history of endometrial disorders, varicose veins of the lower extremities, history of appendectomy, blood serum lactoferrin of more than 1.8 mg/L, interleukin-6 levels more than 2.8 pg/mL. The model has an accuracy of 91%, a sensitivity of 90%, a specificity of 92%, a positive predictive value of 85%, and a negative predictive value of 94%. Conclusion. The established predictors of adenomyosis allow for predicting the risk of adenomyosis in patients with uterine fibroids, facilitating effective treatment choices.
- Open Access
- 15 February 2021
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 23 (1) , 18-24
Endometrial hyperplasia: without atypia and with atypia
The article analyzes and presents data for the last 70 years from the PubMed database on endometrial hyperplasia (EH), which is one of the leaders in the structure of gynecological diseases and the main predictor of endometrial cancer (EC). The chronicle of the EH classification is highlighted with a focus on changing the designation and relevance of adenomatous EH. It is shown how the current classification of EH, due to the fact that a large number of synonyms is limited by two options, allows to maximize the reproducibility of the diagnosis, improve the interaction of the obstetrician-gynecologist with the pathologist and reduce the treatment inefficiency. The results of modern studies on the prevalence and risk factors of EH and EC differ from previously accepted ones and destroy the Bohman triad. The risks of EH development with tamoxifen and menopausal hormone therapy are determined. The data of current research methods aimed at the diagnosis of EH and EC are indicated. The differences in etiopathogenesis, prevalence, diagnosis, risk factors for development and progression to the malignant process presented in the review represent two types of EH (without atypia and with atypia) as completely different endometrial diseases included in the same classification.
- 15 February 2021
- Published by Consilium Medicum in GYNECOLOGY
- Vol. 23 (1) , 18-24
Open AccessEndometrial hyperplasia: without atypia and with atypia
The article analyzes and presents data for the last 70 years from the PubMed database on endometrial hyperplasia (EH), which is one of the leaders in the structure of gynecological diseases and the main predictor of endometrial cancer (EC). The chronicle of the EH classification is highlighted with a focus on changing the designation and relevance of adenomatous EH. It is shown how the current classification of EH, due to the fact that a large number of synonyms is limited by two options, allows to maximize the reproducibility of the diagnosis, improve the interaction of the obstetrician-gynecologist with the pathologist and reduce the treatment inefficiency. The results of modern studies on the prevalence and risk factors of EH and EC differ from previously accepted ones and destroy the Bohman triad. The risks of EH development with tamoxifen and menopausal hormone therapy are determined. The data of current research methods aimed at the diagnosis of EH and EC are indicated. The differences in etiopathogenesis, prevalence, diagnosis, risk factors for development and progression to the malignant process presented in the review represent two types of EH (without atypia and with atypia) as completely different endometrial diseases included in the same classification.
- 1 January 2021
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 21 (2) , 38
Modern technologies of perioperative management of patients
Представлен обзор литературы, посвященный ориентированной на пациентку программе ускоренного восстановления после хирургического лечения. Ключевые позиции программы заключаются в персонифицированном подходе при выполнении оперативного вмешательства с целью оптимизации эмоционально-психического состояния человека, регуляции метаболического ответа, сокращения длительности пребывания в стационаре, сведения к минимуму количества послеоперационных осложнений и повышения удовлетворенности пациенток в целом.
- 1 January 2021
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 21 (2) , 38
Modern technologies of perioperative management of patients
Представлен обзор литературы, посвященный ориентированной на пациентку программе ускоренного восстановления после хирургического лечения. Ключевые позиции программы заключаются в персонифицированном подходе при выполнении оперативного вмешательства с целью оптимизации эмоционально-психического состояния человека, регуляции метаболического ответа, сокращения длительности пребывания в стационаре, сведения к минимуму количества послеоперационных осложнений и повышения удовлетворенности пациенток в целом.
- 1 January 2018
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 18 (6) , 31-40
Modern view on the pathogenesis of proliferative diseases of the uterus
Medical article медицинская статья
- 1 January 2018
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 18 (6) , 31-40
Modern view on the pathogenesis of proliferative diseases of the uterus
Medical article медицинская статья
- 1 January 2017
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 17 (1) , 62
Informative value of conventional diagnostic methods for endometrial proliferative diseases
- 1 January 2017
- Published by Media Sphere Publishing Group in Russian Bulletin of Obstetrician-Gynecologist
- Vol. 17 (1) , 62
Informative value of conventional diagnostic methods for endometrial proliferative diseases